Addlife AB Q3 2026: Strong Earnings, Rising Stock & Future Acquisition PlanAddlife AB’s Q3 2026 earnings beat forecasts, with revenue up 7% YoY and a solid acquisition pipeline, driving a 2.92% stock rise to SEK 180.7.ADDLIFE ABSweden Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated Elliot Mercer 22/10/2026, 20:34 3 minutes to read
